The purpose of the study was to compare 1% ropivacaine and hyaluronidase 75 units/ml with a 1:1 mixture of 2% lignocaine and 0.5% bupivacaine and hyaluronidase 75 units/ml for peribulbar anaesthesia in cataract surgery. We conducted a double-blind randomized trial involving 100 patients. Group 1 received a peribulbar injection of 8 ml of 1% ropivacaine and hyaluronidase 75 units/ml. Group 2 received a peribulbar injection of 8 ml of a 1:1 mixture of 2% lignocaine and 0.5% bupivacaine and hyaluronidase 75 units/ml. Parameters measured were ocular and eyelid movement scores, time suitable for surgery, need for supplementary injections, verbal pain score and complications. No statistical differences were found between the two groups regarding any of the study parameters. Both groups had excellent surgical analgesia and akinesia. We conclude that 1% ropivacaine is a suitable agent for single injection peribulbar anaesthesia for cataract surgery.
Ropivacaine is a new amino amide local anaesthetic. It may possess less potential for cardiac and central nervous system toxicity than bupivacaine and this perceived advantage has led to the increased use of ropivacaine in epidural, peripheral nerve and infiltrative anaesthesia 1 . As far as we are aware this is the first study of the use of ropivacaine in cataract surgery. For adequate regional ophthalmic anaesthesia, perioperative analgesia, akinesia of the globe and the orbicularis muscle are required. This study compared these parameters when either 1% ropivacaine or a 1:1 mixture of 2% lignocaine and 0.5% bupivacaine in combination with hyaluronidase 75 units/ml was used for peribulbar anaesthesia.
METHOD
The study was approved by the local Ethics Committee and all patients gave informed written consent. One hundred consecutive patients scheduled for routine cataract extraction and intraocular lens implantation at Concord General Repatriation Hospital were prospectively randomly allocated to one of two groups. The only exclusion criteria was known allergy to local anaesthetics or hyaluronidase. Patient randomization was by a computer-generated random number sequence. Group 1 received a peribulbar injection of 8 ml 1.0% ropivacaine and hyaluronidase 75 units/ml. Group 2 received a peribulbar injection of an 8 ml mixture of equal volumes of 2% lignocaine and 0.5% bupivacaine with hyaluronidase 75 units/ml. Two 10 ml syringes containing the same local anaesthetic solution were prepared by a pharmacist either the night before or on the morning of the scheduled operation and kept refrigerated in the theatre complex prior to use. The content of the syringes was unknown to the anaesthetist performing the block. Hyaluronidase was added by the anaesthetist performing the block in the following manner. From each syringe, 0.5 ml of local anaesthetic solution was added to an ampoule containing 1500 units of hyaluronidase and following mixing 0.5 ml was redrawn into each syringe. Each 10 ml syringe thus contained 750 units of hyaluronidase. One syringe was used to perform the block. The other remained available in the event of a top-up injection being required.
All patients were assessed before the operation and premedicated with temazepam 10 to 20 mg orally. On arrival in the anaesthetic room a vein on the dorsum of the hand was cannulated and pulse oximetry commenced. The skin around the eye was cleaned using a swab containing povidone iodine. Analgesia of the conjunctiva was provided by two to three drops of 1% amethocaine topically. Approximately two minutes after the last dose of amethocaine, a transdermal injection in the inferolateral quadrant of the orbit using a sharp 38 mm 25-gauge needle was performed. With the eye in the neutral position, the needle was introduced percutaneously at the point between the medial two thirds and lateral one third of the inferior orbital rim along the floor of the orbit. The bevel was facing the globe. The needle was introduced to a depth of appproximately 25 mm as measured from the inferior orbital rim. After gentle negative aspiration 8 ml of solution was injected over 30 to 45s. Following the injection the eyelid was taped down and a mercury weight applied over a gauze pad. Ocular and eyelid movement were assessed at 1 min, 5 min and 10 min after the injection. The mercury weight was reapplied between assessments. Ocular movement was scored for each direction of gaze: abduction, adduction, elevation and depression according to Table 1 . A score of 12 represented normal ocular movement and a score of 0 represented absence of ocular movement. Forced eyelid closure was scored as shown in Table 1 . An ocular movement score (OMS) of 4 or less was considered adequate for surgery. If at 10 minutes the score was 5 or more a supplementary injection of 2 to 4 ml of the same local anaesthetic solution was performed using the same injection technique as previously described. Additional assessments were made at 2 minute intervals. The time at which the block reached an OMS 4 or less was noted. At the completion of surgery patients were asked to verbally score any pain they may have experienced during the operation (0, no pain, 10, worst pain ever experienced). Each patient's electrocardiogram (ECG) was monitored continuously and non-invasive blood pressure (NIBP) recorded every 10 min during the operation. If a patient complained of pain during surgery, amethocaine 1% was applied topically to the ocular surface. Any complications during or after the injection were noted.
Demographic data were analysed using Student's t-test for age and the Chi-squared test for gender. Ocular movement scores were analysed using the Wilcoxon rank sum test. Eyelid movement scores were analysed using the Fisher's exact test. The time to reach an OMS of 4 was analysed using the Wilcoxon rank sum test. Pain scores were analysed using the Wilcoxon rank sum test. The need for top-up injections and complications were analysed using the Chi-squared test. A P value of <0.05 was considered significant.
RESULTS
The demographic data are shown in Table 2 . There is no significant difference in the age (P=0.11) and sex (Chi-squared value 1.03, P=0.31) between the two groups.
There was no significant difference in the OMS at 1, 5 and 10 minutes between the groups (Table 3) .
Eyelid akinesia was satisfactory at 10 minutes in both groups. There was no significant difference in the eyelid movement score at 1, 5 and 10 minutes between the groups (Fisher's exact test; P=0.50, 0.08 and 0.50).
There was no significant difference in pain scores between the two groups ( Table 3 ).
The median time taken to reach an OMS 4 was 5 minutes (interquartile range 13) in Group 1, and 5 minutes (interquartile range 9) in Group 2. This was not significant (Wilcoxon rank sum test, P (twosample)=0.82).
Supplementary injection was needed in 15 patients (30%) in Group 1 and 13 patients (26%) in Group 2 because the block was still inadequate at 10 min. There was no significant difference between the two groups (Chi-squared value 0.05, P=0.82).
Complications did not differ between the two groups (Chi-squared value 1.75, P=0.19). Topical 1% amethocaine was required in three patients in Group 1 and eight patients in Group 2 who complained of intraoperative pain. Chemosis was noted in eight patients in Group 1 and six in Group 2. Bruising at the site of injection was noted in four patients in Group 2. No serious complications were seen in either group.
DISCUSSION
A mixture of lignocaine and bupivacaine in varying concentrations is the local anaesthetic preferred by many anaesthetists for peribulbar block. Lignocaine is added to bupivacaine to reduce the latency to onset of block while bupivacaine significantly prolongs the duration of surgical anaesthesia. Unfortunately combining drugs has some disadvantages. As premixed solutions of lignocaine and bupivacaine are not available, there is the potential for bacterial contamination during preparation. Once prepared the solution must be used within a short period as the mixture has a limited shelf-life. The use of two drugs increases the potential for the wrong drug to be used in error. Additionally, bupivacaine has a narrow therapeutic index and accidental anaesthetic deaths have occurred 2 . The use of a single agent with a wide therapeutic index when performing a regional anaesthetic is therefore desirable. We have shown that ropivacaine provides globe and eyelid akinesia and surgical analgesia which is comparable to a mixture of 2% lignocaine and 0.5% bupivacaine when used for single injection peribulbar block in combination with hyaluronidase.
The peribulbar technique involves the injection of local anaesthetic outside the muscle cone. This reduces the risk of optic nerve damage and brainstem anaesthesia. Nevertheless, care needs to be taken as reports of brainstem anaesthesia still occur 3 . If a 38 mm needle is used it should not be inserted more than 31 mm beyond the inferior orbital rim 4 . Many variations of the peribulbar technique have been described 5 . We chose to use a single inferolateral injection using a large volume of local anaesthetic. This technique has been shown to be effective, avoids a second superior injection that is often painful and diminishes complications 6 . Eyelid akinesia occurs due to spread of the local anaesthetic through connective tissue planes and a separate facial nerve block is usually not required. Hyaluronidase was used as this has been shown to improve the spread of the local anaesthetic through the orbital connective tissues 7 . In our study akinesia of the orbicularis muscle did not differ between the groups. Although we did not encounter any problems with the technique used, large volumes may not be appropriate for individuals of Asian origin who have small orbits. Conversely, larger volumes may be required in some patients with capacious orbits.
The lack of a standardized ocular and eyelid movement scoring system makes comparison between the various peribulbar techniques difficult. The system we used was first described by Brahma et al and has since been validated by others 8, 9 . In our study the median time at which the block was considered suitable for surgery was five minutes in both groups. Döpfmer et al report a median time of 12 min for a mixture of 2% lignocaine and 0.75% bupivacaine and 10 min for 3% prilocaine using a medial compartment injection 9 . Zahl et al reported an onset time for complete orbital akinesia of 5.3 min for a pH-adjusted solution of 0.75% bupivacaine although this study used a superior and inferior periorbital injection 10 .
The need for a supplementary injection was 30% in the ropivacaine group and 26% in the lignocaine/ bupivacaine group. This is a relatively high reblock rate and probably reflects the requirement for almost complete ocular akinesia prior to starting surgery. In other published studies the reblock rate varied from 63% to 1.2% [9] [10] [11] [12] [13] . Comparison between these studies is difficult due to the different local anaesthetic mixtures and volumes used, addition of hyaluronidase, injection site and methodology.
Patients who complained of intraoperative pain were managed with additional topical amethocaine. Alternative techniques available for the management of intraoperative pain include the subconjunctival injection of local anaesthetic, the instillation of local anaesthetic in the sub-Tenon's space or further peribulbar injections.
Bupivacaine is added to lignocaine for peribulbar anaesthesia to prolong the duration of action of the local anaesthetic mixture. Although we did not specifically study the duration of anaesthesia and analgesia, no patient complained of pain towards the end of surgery despite delays of up to 1.5 hours. This suggests that ropivacaine when used for peribulbar anaesthesia and analgesia has a duration of action which is comparable to bupivacaine.
When used in low concentrations, ropivacaine provides analgesia with minimal motor block. As with other local anaesthetics, as the concentration is increased the onset time is decreased and the degree of motor block increased. Due to its lower potential for toxicity, this enables ropivacaine to be used for surgical anaesthesia in concentrations up to 1% 14 .
Our study demonstrates that 1% ropivacaine produces orbital akinesia and surgical anaesthesia which is comparable to that produced by a mixture of 2% lignocaine and 0.5% bupivacaine. Furthermore, when used as a 1% solution onset time is not significantly prolonged.
